110 related articles for article (PubMed ID: 16934755)
1. Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.
Gallo RM; Bryant I; Fry R; Williams EE; Riese DJ
Biochem Biophys Res Commun; 2006 Oct; 349(1):372-82. PubMed ID: 16934755
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
[TBL] [Abstract][Full Text] [Related]
3. A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines.
Williams EE; Trout LJ; Gallo RM; Pitfield SE; Bryant I; Penington DJ; Riese DJ
Cancer Lett; 2003 Mar; 192(1):67-74. PubMed ID: 12637154
[TBL] [Abstract][Full Text] [Related]
4. Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.
Gallo RM; Bryant IN; Mill CP; Kaverman S; Riese DJ
J Cancer Res Ther Oncol; 2013 Aug; 1(1):10. PubMed ID: 24791013
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
[TBL] [Abstract][Full Text] [Related]
6. A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
Vidal GA; Clark DE; Marrero L; Jones FE
Oncogene; 2007 Jan; 26(3):462-6. PubMed ID: 16832345
[TBL] [Abstract][Full Text] [Related]
7. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
[TBL] [Abstract][Full Text] [Related]
8. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.
Hobbs SS; Cameron EM; Hammer RP; Le AT; Gallo RM; Blommel EN; Coffing SL; Chang H; Riese DJ
Oncogene; 2004 Jan; 23(4):883-93. PubMed ID: 14661053
[TBL] [Abstract][Full Text] [Related]
9. The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056.
Gallo RM; Riese DJ
Growth Factors; 2007 Oct; 25(5):329-33. PubMed ID: 18236211
[TBL] [Abstract][Full Text] [Related]
10. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
11. Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
Penington DJ; Bryant I; Riese DJ
Cell Growth Differ; 2002 Jun; 13(6):247-56. PubMed ID: 12114214
[TBL] [Abstract][Full Text] [Related]
12. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.
Sundvall M; Peri L; Määttä JA; Tvorogov D; Paatero I; Savisalo M; Silvennoinen O; Yarden Y; Elenius K
Oncogene; 2007 Oct; 26(48):6905-14. PubMed ID: 17486069
[TBL] [Abstract][Full Text] [Related]
13. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
Ligęza J; Ligęza J; Klein A
Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
[TBL] [Abstract][Full Text] [Related]
14. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
[TBL] [Abstract][Full Text] [Related]
15. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
Elenius K; Choi CJ; Paul S; Santiestevan E; Nishi E; Klagsbrun M
Oncogene; 1999 Apr; 18(16):2607-15. PubMed ID: 10353604
[TBL] [Abstract][Full Text] [Related]
17. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective.
Chuu CP; Chen RY; Barkinge JL; Ciaccio MF; Jones RB
Mol Cancer Res; 2008 Jun; 6(6):885-91. PubMed ID: 18567793
[TBL] [Abstract][Full Text] [Related]
18. Signaling mechanisms that mediate invasion in prostate cancer cells.
Bonaccorsi L; Marchiani S; Muratori M; Carloni V; Forti G; Baldi E
Ann N Y Acad Sci; 2004 Dec; 1028():283-8. PubMed ID: 15650253
[TBL] [Abstract][Full Text] [Related]
19. Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src.
Ishibashi K; Fukumoto Y; Hasegawa H; Abe K; Kubota S; Aoyama K; Kubota S; Nakayama Y; Yamaguchi N
J Cell Sci; 2013 Jan; 126(Pt 2):625-37. PubMed ID: 23230144
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid phosphatase.
Fleisig H; El-Din El-Husseini A; Vincent SR
Neuroscience; 2004; 127(1):91-100. PubMed ID: 15219672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
